Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Gastrointestinal Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type

Title

CLDK378AUS23
Sponsor:
Novatis
New.jpg

Patient has a confirmed diagnosis of a select solid tumor (except with a primary diagnosis of ALK+ NSCLC) or hematologic malignancy and is in need of treatment because of progression or relapse

Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 7 – Ceritinib (LDK378) for patients whose tumors have aberrations in ALK or ROS1

CALGB/SWOG C80702

Adjuvant Therapy, Colon Cancer Stage III

A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer.

NSABP
MPR-1
Sponsor:
NSABP

Metastatic colorectal cancer
formalin-fixed paraffin-embedded (FFPE) tissue blocks from the primary colorectal tumor with corresponding pathology report must be available for release

 NSABP Patient Registry and Biospecimen Profiling Repository

OBS13597
Sponsor:
Sanofi

 

metastatic colorectal cancer

Prospective international observational cohort non-comparative study describing the safety and effectiveness of ZALTRAP® administered in combination with FOLFIRI for the treatment of patients with metastatic colorectal cancer in current clinical practice: A Post-Authorisation Safety Study (PASS)

  Holy Cross Hospital
  Holy Cross Germantown Hospital
  Icon-LinkedIn.png 

© 2015  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000
trinity-health.org